Analyzing Antibiotic Resistance in Clinical Mycobacterium tuberculosis Isolates using Microplate Alamar Blue Assay
Journal of Medical Microbiology and Infectious Diseases · 2023
DOI: 10.61186/jommid.11.4.174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology and Infectious Diseases, 2023. Verfasst von Kamal Ahmadi und 6 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Tuberculosis, caused by Mycobacterium tuberculosis, is one of the most common infectious diseases worldwide.Epidemiological studies of M. tuberculosis drug resistance are critical for improving patient treatment approaches and controlling the spread of tuberculosis.The present study aimed to determine antibiotic resistance among M. tuberculosis clinical isolates using the Microplate Alamar Blue Assay (MABA).
Methods
In this descriptive cross-sectional study, 25 M. tuberculosis isolates from clinical samples were identified and confirmed using standard microbiological and biochemical tests.Then, the MIC for the antibiotics Bedaquiline, isoniazid, rifampin, ethambutol, ofloxacin, moxifloxacin, capreomycin, and streptomycin was determined using the MABA method.The results were analyzed using SPSS version 16 software.
Results
Among the 25 investigated isolates, the frequencies for MDR, Pre-XDR, and XDR isolates were 20%, 8%, and 32%, respectively.The highest rate of drug resistance was to isoniazid (80%), rifampicin, and ethambutol (76%), and the highest rate of sensitivity was to moxifloxacin (68%).The frequency of isoniazid mono-resistance and rifampicin mono-resistance was 5 cases (50%) and 4 cases (40%), respectively.
Conclusion
Our study revealed an alarming rate of MDR and XDR M. tuberculosis strains, indicating that current first-line treatments may be ineffective for a significant number of patients.The bedaquiline resistance among the isolates with no history of previous exposure to this drug suggests unexplored resistance mechanisms.Molecular techniques to accurately identify these mechanisms may contribute to developing more effective treatment strategies to combat drug-resistant tuberculosis.
Zitieren
APA
Ahmadi, K., Madadi-Goli, N., Masoumi, M., Nasehi, M., Siadat, S. D., Vaziri, F., & Fateh, A. (2023). Analyzing Antibiotic Resistance in Clinical Mycobacterium tuberculosis Isolates using Microplate Alamar Blue Assay. Journal of Medical Microbiology and Infectious Diseases. https://doi.org/10.61186/jommid.11.4.174
Vancouver
Ahmadi K, Madadi-Goli N, Masoumi M, Nasehi M, Siadat SD, Vaziri F, et al. Analyzing Antibiotic Resistance in Clinical Mycobacterium tuberculosis Isolates using Microplate Alamar Blue Assay. Journal of Medical Microbiology and Infectious Diseases. 2023. doi:10.61186/jommid.11.4.174
BibTeX
@article{Ahmadi2023,
author = {Ahmadi, Kamal and Madadi-Goli, Nahid and Masoumi, Morteza and Nasehi, Mahshid and Siadat, Seyed Davar and Vaziri, Farzam and Fateh, Abolfazl},
title = {Analyzing Antibiotic Resistance in Clinical Mycobacterium tuberculosis Isolates using Microplate Alamar Blue Assay},
journal = {Journal of Medical Microbiology and Infectious Diseases},
year = {2023},
doi = {10.61186/jommid.11.4.174}
}
EUVIMED